The duration of hyperglycemia, nutritional intake and insulin treatment should be considered modifying factors; in addition, several confounding factors should be considered: perinatal characteristics, morbidities of prematurity, episodes of hypoglycemia and socio-demographic characteristics. This evidence concerns the gene INS and Hyperglycemia.